Current:Home > MyThese LSD-based drugs seem to help mice with anxiety and depression — without the trip-DB Wealth Institute B2 Expert Reviews
These LSD-based drugs seem to help mice with anxiety and depression — without the trip
View Date:2024-12-23 19:45:07
Drugs like magic mushrooms and LSD can act as powerful and long-lasting antidepressants. But they also tend to produce mind-bending side-effects that limit their use.
Now, scientists report in the journal Nature that they have created drugs based on LSD that seem to relieve anxiety and depression – in mice – without inducing the usual hallucinations.
"We found our compounds had essentially the same antidepressant activity as psychedelic drugs," says Dr. Bryan Roth, an author of the study and a professor of pharmacology at UNC Chapel Hill School of Medicine. But, he says, "they had no psychedelic drug-like actions at all."
The discovery could eventually lead to medications for depression and anxiety that work better, work faster, have fewer side effects, and last longer.
The success is just the latest involving tripless versions of psychedelic drugs. One previous effort created a hallucination-free variant of ibogaine, which is made from the root bark of a shrubby plant native to Central Africa known as the iboga tree.
"It's very encouraging to see multiple groups approach this problem in different ways and come up with very similar solutions," says David E. Olson, a chemical neuroscientist at the University of California, Davis, who led the ibogaine project.
An unexpected find
The new drug comes from a large team of scientists who did not start out looking for an antidepressant.
They had been building a virtual library of 75 million molecules that include an unusual structure found in a number of drugs, including the psychedelics psilocybin and LSD, a migraine drug (ergotamine), and cancer drugs including vincristine.
The team decided to focus on molecules that affect the brain's serotonin system, which is involved in regulating a person's mood. But they still weren't looking for an antidepressant.
Roth recalls that during one meeting, someone asked, "What are we looking for here anyway? And I said, well, if nothing else, we'll have the world's greatest psychedelic drugs."
As their work progressed, though, the team realized that other researchers were showing that the psychedelic drug psilocybin could relieve depression in people. And the effects could last a year or more, perhaps because the drug was helping the brain rewire in a way that was less prone to depression.
"There [were] really interesting reports about people getting great results out of this after just a few doses," says Brian Shoichet, an author of the study and a professor in the pharmaceutical chemistry department at the University of California, San Francisco.
So the team began refining their search to find molecules in their library that might act the same way.
Ultimately, they selected two.
"They had the best properties," Shoichet says. "They were the most potent, and when you gave them to a mouse, they got into the brain at the highest concentrations."
The two molecules were also "extremely effective" at relieving symptoms of depression in mice, Roth says.
How to tell when a mouse is tripping
Scientists have shown that a depressed mouse tends to give up quickly when placed in an uncomfortable situation, like being dangled from its tail. But the same mouse will keep struggling if it gets an antidepressant drug like Prozac, ketamine, or psilocybin.
Mice also kept struggling when they got the experimental molecules.
But they didn't exhibit any signs of a psychedelic experience, which typically causes a mouse to twitch its nose in a distinctive way. "We were surprised to see that," Roth says.
The team says it needs to refine these new molecules before they can be tried in people. One reason is that they appear to mimic LSD's ability to increase heart rate and raise blood pressure.
But if the approach works, it could overcome a major obstacle to using psychedelic drugs to treat depression.
Currently, treatment with a psychedelic requires medical supervision and a therapist to guide a patient through their hallucinatory experience.
That's an impractical way to treat millions of people with depression, Shoichet says.
"Society would like a molecule that you can get prescribed and just take and you don't need a guided tour for your trip," he says.
Another advantage of the new approach is that the antidepressant effects would occur within hours of taking the drug, and might last a year or more. Drugs like Prozac and Zoloft often take weeks to work, and must be taken every day.
Drugs based on psychedelics "take us a step closer to a cure, rather than simply treating disease symptoms," Olsen says.
veryGood! (19817)
Related
- Louisiana man kills himself and his 1-year-old daughter after a pursuit
- Poland bank governor says interest rate cut justified by falling inflation
- San Antonio police say couple safe after kidnapping; 2 charged, 1 suspect at large
- Ex-Trump aide Peter Navarro found guilty of contempt of Congress
- Minnesota county to pay $3.4M to end lawsuit over detainee’s death
- Foreign Relations chair seeks answers from US oil firms on Russia business after Ukraine invasion
- Prince Harry to attend charity event in London -- but meeting up with the family isn’t on the agenda
- Japan’s Kishida says China seafood ban contrasts with wide support for Fukushima water release
- Nicole Scherzinger receives support from 'The View' hosts after election post controversy
- Dozens of migrants rescued off Greek island of Lesbos. Search is under way for woman feared missing
Ranking
- Olivia Munn Says She “Barely Knew” John Mulaney When She Got Pregnant With Their Son
- Spain soccer chief Luis Rubiales accused of sexual assault by player Jenni Hermoso for unwanted kiss
- Federal judge deals another serious blow to proposed copper-nickel mine on edge Minnesota wilderness
- Without proper air conditioning, many U.S. schools forced to close amid scorching heat
- Halle Berry Rocks Sheer Dress She Wore to 2002 Oscars 22 Years Later
- Michigan State Police shoot, arrest suspect in torching of four of the agency’s cruisers
- Most federal oversight of Seattle Police Department ends after more than a decade
- Woman charged with abandoning newborn girl in New Jersey park nearly 40 years ago
Recommendation
-
Driver dies after crashing on hurricane-damaged highway in North Carolina
-
Trump may try to have his Georgia election interference case removed to federal court
-
Former British police officers admit sending racist messages about Meghan and others
-
UAW chief says time is running out for Ford, GM and Stellantis to avoid a strike
-
The Bachelorette's Desiree Hartsock Gives Birth, Welcomes Baby No. 3 With Chris Siegfried
-
A Democratic prosecutor is challenging her suspension by Republican Florida Gov. Ron DeSantis
-
Judge says New York AG's $250M lawsuit against Trump will proceed without delay
-
High school football coach at center of Supreme Court prayer case resigns after first game back